Call for Abstract
Scientific Program
4th International Congress on Addictive Behavior and Dual Diagnosis, will be organized around the theme “Exploring Advance Methodologies for Addiction & Mental Disorders Treatment”
Dual Diagnosis 2019 is comprised of 22 tracks and 125 sessions designed to offer comprehensive sessions that address current issues in Dual Diagnosis 2019.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Cannabis - hallucinations and delusions
- Track 1-2Cocaine - Dementia
- Track 1-3Marijuana - Schizophrenia
- Track 1-4Opioids - Insomnia
- Track 1-5Ketamine - Antisocial personality disorders
- Track 1-6Benzodiazepine - Sedation & Hypnotism
- Track 1-7Advances in Neurotoxicology
- Track 1-8Substance abuse disorders
- Track 1-9Molecular Biology and Genetics
- Track 1-10Smoking
- Track 8-1Neurodegenerative Disorder
- Track 8-2Holistic and Alternative Treatment Approaches
- Track 8-3Mindfulness
- Track 8-4Addictive Brain Disorder and Neurosurgery
- Track 9-1Mental Health
- Track 9-2Emotional health
- Track 9-3Behavioral health sciences
- Track 9-4Spiritual sciences
- Track 9-5Psychology and Education
- Track 9-6Motivational interviewing
- Track 9-7Contingency management
- Track 9-8Residential treatment
- Track 9-9Psychodynamic therapy
- Track 9-10Dialectical behavioral therapy
- Track 9-11Cognitive impairment
- Track 10-1Detoxification stage
- Track 10-2Relapse and Management
- Track 10-3Alcohol Facts
- Track 10-4Trans cranial Magnetic Stimulation
- Track 10-5Psychotropic substance abusers
- Track 10-6Residential Drug Rehabilitation Program
- Track 11-1Drug receptors
- Track 11-2Drugs and their effects on addiction
- Track 11-3Drug tolerance
- Track 11-4Drug dependence
- Track 11-5Drug Addiction and Consequences
- Track 12-1NSAIDS Addiction
- Track 12-2Cocaine addiction
- Track 12-3Hallucinogens Abuse
- Track 12-4Tobacco abuse
- Track 12-5Drug addiction diagnosis
- Track 12-6Drug addiction recovery
- Track 12-7Durg use and toxicity
- Track 12-8Cognitive impairment
- Track 12-9Psychodynamic therapy
- Track 12-10Post-traumatic stress disorder
- Track 13-1Clinical Depression
- Track 13-2Major Depression
- Track 13-3Advanced Depression
- Track 13-4Severe Depression
- Track 13-5Advances in Depression test
- Track 13-6Advances in clinical depression disorders
- Track 13-7Obsessive Compulsive Disorder
- Track 14-1Personality disorder
- Track 14-2Anxiety disorders
- Track 14-3Diagnosing bipolar test
- Track 14-4Manic bipolar disorder
- Track 14-5Bipolar schizophrenia
- Track 14-6Advanced therapeutics in Bipolar treatment
- Track 14-7Bipolar Psychiatrists
- Track 15-1Drug dependence
- Track 15-2Drug Abuse and Mental Health
- Track 15-3Drug induced disorders
- Track 15-4HIV/AIDS
- Track 15-5Alcohol and Viral Hepatitis
- Track 15-6NSAIDS and Mental illness
- Track 15-7Drug addiction in Children and Adolescents
- Track 16-1Post-traumatic stress disorder
- Track 16-2Emergency Mental health
- Track 16-3Antisocial Personality Disorder
- Track 16-4Behavioral addiction
- Track 16-5Sexual Addiction
- Track 16-6Gambling Addiction
- Track 16-7Internet Addiction
- Track 16-8Food addiction
- Track 16-9Surgical addiction
- Track 16-10Alcoholism- Amnesia, anxiety, depression
- Track 16-11Amphetamines- schizophrenia
- Track 17-1Addiction & Toxicology
- Track 17-2Alcohol detoxification using chemotherapeutic agents
- Track 17-3Alcohol detoxification using chemotherapeutic agents
- Track 17-4Alcoholic Liver Disease
- Track 17-5Lung Health and Immunity
- Track 18-1Marijuana use
- Track 18-2Opioid dependence
- Track 18-3Opioid treatment
- Track 18-4Advances in addiction psychology
- Track 18-5Anxiety, Depression and Insomnia
- Track 18-6Attention-deficit hyperactivity disorder
- Track 18-7Obsessive-Compulsive Disorder
- Track 19-1Borderline personality therapy
- Track 19-2Integrated treatment for dual disorders
- Track 19-3Nicotine replacement therapy
- Track 19-4Cognitive behavioral therapy
- Track 19-5Multidimensional family therapy
- Track 19-6Psychodynamic therapy
- Track 19-7Dialectical behavioral therapy
- Track 19-8Prenatal Alcohol Exposure
- Track 20-1NSAIDS and Mental illness
- Track 20-2Drug addiction in Children and Adolescents
- Track 20-3Drug dependence
- Track 20-4Drug Abuse and Mental Health
- Track 20-5Drug induced disorders
- Track 20-6HIV/AIDS
- Track 20-7Alcohol and Viral Hepatitis
- Track 20-8Adaptive Immune System
- Track 20-9Lung Health and Immunity
- Track 20-10Alcoholic Liver Disease
- Track 20-11Neurogenetics of Substance Related Disorders
- Track 20-12Mental health and symptoms
- Track 21-1Philosophical and ethical themes in mental health
- Track 21-2Mental health across the life span
- Track 21-3Mental health in developing regions
- Track 21-4Mental health services and policies
- Track 22-1Marijuana addiction
- Track 22-2Alcoholism
- Track 22-3Psychosis
- Track 22-4Schizophrenia
- Track 22-5Alcohol detoxification using chemotherapeutic agents
- Track 22-6Autism spectrum disorder
- Track 22-7Addiction and brain disorders
- Track 22-8alcoholism and brain
- Track 22-9Pain management
- Track 22-10Pharmacotherapies
- Track 22-11Alcoholic dementia